Cargando…
Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant
Redox-active substances and their combinations, such as of quinone/ascorbate and in particular menadione/ascorbate (M/A; also named Apatone®), attract attention with their unusual ability to kill cancer cells without affecting the viability of normal cells as well as with the synergistic anticancer...
Autores principales: | Bakalova, Rumiana, Semkova, Severina, Ivanova, Donika, Zhelev, Zhivko, Miller, Thomas, Takeshima, Tsuguhide, Shibata, Sayaka, Lazarova, Dessislava, Aoki, Ichio, Higashi, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652615/ https://www.ncbi.nlm.nih.gov/pubmed/33204397 http://dx.doi.org/10.1155/2020/6212935 |
Ejemplares similares
-
Redox-Cycling “Mitocans” as Effective New Developments in Anticancer Therapy
por: Bakalova, Rumiana, et al.
Publicado: (2023) -
“Redox Imaging” to Distinguish Cells with Different Proliferative Indexes: Superoxide, Hydroperoxides, and Their Ratio as Potential Biomarkers
por: Zhelev, Zhivko, et al.
Publicado: (2019) -
Tolerable treatment of glioblastoma with redox-cycling ‘mitocans': a comparative study in vivo
por: Sumiyoshi, Akira, et al.
Publicado: (2023) -
Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State
por: Sumiyoshi, Akira, et al.
Publicado: (2022) -
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
por: Zhelev, Zhivko, et al.
Publicado: (2022)